Table 2.
Total Omega-3 |
Total Omega-6 |
Omega-6/Omega-3 Ratio |
||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|
Model 1 |
Model 2 |
Model 1 |
Model 2 |
Model 1 |
Model 2 |
|||||||
Coefficient | P Value | Coefficient | P Value | Coefficient | P Value | Coefficient | P Value | Coefficient | P Value | Coefficient | P Value | |
FEV1, % predicted* | 5.99 (−0.73 to 12.72) | 0.08 | 6.90 (−0.09 to 13.89) | 0.05 | −1.39 (−2.45 to −0.34) | <0.01 | −1.50 (−2.57 to −0.43) | 0.01 | −3.09 (−6.25 to 0.08) | 0.06 | −3.51 (−6.73 to −0.29) | 0.04 |
CAT score† | −4.83 (−7.85 to −1.81) | <0.01 | −4.54 (−7.76 to −1.31) | 0.01 | 0.93 (0.46 to 1.40) | <0.01 | 0.84 (0.34 to 1.34) | <0.01 | 2.14 (0.70 to 3.57) | <0.01 | 1.95 (0.45 to 3.45) | 0.01 |
SGRQ total‡ | −11.57 (−18.23 to −4.91) | <0.01 | −11.11 (−18.19 to −4.03) | <0.01 | 2.16 (1.11 to 3.20) | <0.01 | 1.95 (0.85 to 3.05) | <0.01 | 5.28 (2.13 to 8.44) | <0.01 | 4.93 (1.66 to 8.20) | <0.01 |
CCQ‡ | −0.60 (−1.00 to −0.20) | <0.01 | −0.58 (−1.00 to −0.15) | 0.01 | 0.09 (0.03 to 0.16) | <0.01 | 0.09 (0.02 to 0.15) | 0.01 | 0.24 (0.05 to 0.43) | 0.01 | 0.23 (0.04 to 0.43) | 0.02 |
6MWD§ | 194.10 (−15.51 to 403.70) | 0.07 | 178.74 (−43.82 to 401.30) | 0.11 | −32.06 (−63.39 to −0.72) | 0.05 | −30.96 (−64.84 to 2.92) | 0.07 | −78.65 (−172.73 to 15.44) | 0.07 | −79.41 (−176.28 to 17.46) | 0.11 |
mMRC, OR‡ | 0.48 (0.19 to 1.22) | 0.12 | 0.42 (0.15 to 1.22) | 0.11 | 1.19 (1.02 to 1.39) | 0.02 | 1.23 (1.04 to 1.47) | 0.02 | 1.46 (0.97 to 2.19) | 0.07 | 1.52 (0.96 to 2.42) | 0.07 |
Severe exacerbation, OR¶ | 0.06 (0.01 to 0.54) | 0.01 | 0.08 (0.01 to 0.73) | 0.03 | 1.58 (1.12 to 2.21) | <0.01 | 1.48 (1.05 to 2.09) | 0.02 | 2.53 (1.29 to 4.99) | <0.01 | 2.25 (1.09 to 4.64) | 0.03 |
Any exacerbation, OR¶ | 0.33 (0.09 to 1.27) | 0.11 | 0.31 (0.07 to 1.38) | 0.13 | 1.30 (1.06 to 1.61) | 0.01 | 1.30 (1.03 to 1.64) | 0.02 | 1.47 (0.93 to 2.32) | 0.10 | 1.41 (0.84 to 2.38) | 0.19 |
Definition of abbreviations: 6MWD = 6-minute-walk distance; CAT = COPD Assessment Test; CCQ = Clinical COPD Questionnaire; FEV1 = forced expiratory volume in 1 second; mMRC = modified Medical Research Council dyspnea scale; OR = odds ratio; SGRQ = St. George’s Respiratory Questionnaire.
Coefficient represents predicted change in outcome, or odds ratio (OR) where noted, with 95% confidence interval per 1-g increase in total omega-3 or omega-6 intake. Model 1 is adjusted for alternate fatty acid. Model 2 includes the following covariates: age, sex, race (white vs. others), education (high school or less vs. more than high school), body mass index, total calories, pack-years of smoking, FEV1 percent predicted (except when FEV1 percent predicted is an outcome), and alternate fatty acid. Coefficients reaching statistical significance (P < 0.05) are shown in boldface.
Model 1, n = 111; model 2, n = 111.
Model 1, n = 107; model 2, n = 106.
Model 1, n = 111; model 2, n = 110.
n = 76.
Model 1, n = 112; model 2, n = 111.